Literature DB >> 321206

Clinical use of verapamil.

J K Vohra.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 321206     DOI: 10.2165/00003495-197713030-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  8 in total

1.  [(N-methyl-N-homoveratryl)-gamma-aminopropyl] -3,4-dimethoxyphenylacetonitrile, its detection in biological materials and its behavior in blood].

Authors:  W APPEL
Journal:  Arzneimittelforschung       Date:  1962-06

2.  Haemodynamic effect of intravenous verapamil in controlled atrial fibrillation.

Authors:  G Sloman; J Spokes; J Ramshaw; J Vohra
Journal:  Aust N Z J Med       Date:  1975-10

Review 3.  Verapamil and the myocardium.

Authors:  W G Nayler; D Krikler
Journal:  Postgrad Med J       Date:  1974-07       Impact factor: 2.401

4.  Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.

Authors:  R A Spurrell; D M Krikler; E Sowton
Journal:  Br Heart J       Date:  1974-03

5.  Effect of verapamil in obstructive airways disease.

Authors:  T Ringqvist
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

6.  Verapamil in cardiology.

Authors:  D Krikler
Journal:  Eur J Cardiol       Date:  1974-08

7.  Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris.

Authors:  B Livesley; P F Catley; R C Campbell; S Oram
Journal:  Br Med J       Date:  1973-02-17

8.  Clinical experience with verapamil.

Authors:  J Vohra; D Hunt; G Sloman
Journal:  Med J Aust       Date:  1975-09-13       Impact factor: 7.738

  8 in total
  3 in total

1.  Preliminary investigation of the efficacy of sublingual verapamil in the management of acute atrial fibrillation and flutter.

Authors:  S Fort; M J Lewis; D K Luscombe; D N John
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

Review 2.  Adverse reactions to calcium antagonists.

Authors:  J G Lewis
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

3.  Drug treatment of chronic stable angina pectoris.

Authors: 
Journal:  Br Med J       Date:  1978-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.